SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Icebrg who wrote (3428)10/22/2002 9:37:24 AM
From: biostruggle  Read Replies (1) of 10345
 
You may be right or wrong. Disclosure on whether Elan must maintain 1:1 ratio of collateral is not clear from disclosure.

Page 92 annual report.

"The investments and cash in EPIL III are held as security against the EPIL III senior guaranteed notes. These
assets are not available for distribution outside EPIL III. The EPIL III senior guaranteed notes are guaranteed on a subordinated basis by Elan
and, consequently, in accordance with the provisions of Financial Reporting Standard 5, “Reporting the Substance of Transactions” (“FRS 5”),
the EPIL III senior guaranteed notes, investments and cash are included separately on the Company’s balance sheet."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext